[1] Gingras A C, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR[J]. Genes Dev, 2001, 15(7): 807-826. [2] Sarbassov D D, Ali S M, Sabatini D M. Growing roles for the mTOR pathway[J]. Curr Opin Cell Biol, 2005, 17(6): 596-603. [3] Stepkowski S M, Chen H, Daloze P, et al. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat[J]. Transplantation, 1991, 51(1): 22-26. [4] Granger D K, Cromwell J W, Chen S C, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy[J]. Transplantation, 1995, 59(2): 183-186. [5] Harrison D E, Strong R, Sharp Z D, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice[J]. Nature, 2009, 460(7253): 392-395. [6] Maiese K. Driving neural regeneration through the mammalian target of rapamycin[J]. Neural Regen Res, 2014, 9(15): 1413-1417. [7] Vogt P K. PI 3-kinase, mTOR, protein synthesis and cancer[J]. Trends Mol Med, 2001, 7(11): 482-484. [8] Czerninski R, Amornphimoltham P, Patel V, et al. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model[J]. Cancer Prev Res (Phila), 2009, 2(1): 27-36. [9] Iglesias-Bartolome R, Patel V, Cotrim A, et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis[J]. Cell Stem Cell, 2012, 11(3): 401-414. [10] Morgan-Bathke M, Harris Z I, Arnett D G, et al. The Rapalogue, CCI-779, improves salivary gland function following radiation[J]. PLoS One, 2014, 9(12): e113183. [11] 袁进,顾为望. 小型猪作为人类疾病动物模型在生物医学研究中的应用[J]. 动物医学进展,2011,32(2): 108-111. [12] 单广夷,付成,陈昂,等. 雷帕霉素对膀胱癌5637细胞增殖及细胞周期的影响[J]. 中国医科大学学报,2015,44(3):230-233. [13] Jimeno A, Rudek M A, Kulesza P, et al. Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors[J]. J Clin Oncol, 2008, 26(25): 4172-4179. [14] Ireland R. Pediatrics: Sirolimus may stunt growth of kidney-transplanted children[J]. Nat Rev Nephrol, 2011, 7(6): 303. [15] Kahan B D, Kramer W G. Median effect analysis of efficacy versus adverse effects of immunosuppressants[J]. Clin Pharmacol Ther, 2001, 70(1): 74-81. [16] Groth C G, Backman L, Morales J M, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group[J]. Transplantation, 1999, 67(7): 1036-1042. [17] Yatscoff R W, Wang P, Chan K, et al. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations[J]. Ther Drug Monit, 1995, 17(6): 666-671. [18] 刘杰,杜雨轩,王望,等. 雷帕霉素对野百合碱诱导的大鼠肺动脉高压及肺血管重构的影响 [J]. 首都医科大学学报,2013,34(4):554-558. |